Benzinga | Jan 19, 2021 06:28AM EST

HC Wainwright & Co. Maintains Buy on IGM Biosciences, Raises Price Target to $114

HC Wainwright & Co. maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $88 to $114.